← Back to all earnings calls

Avalo Therapeutics, Inc. Q2 FY2023 Earnings Call

Avalo Therapeutics, Inc. (AVTX)

Earnings Call FY2023 Q2 Call date: 2023-08-03 Concluded

Share

Quarter scorecard

Revenue

$643,000

-37.8% YoY

Diluted EPS

$-140.73

Net income

$

Documents & deck